For WELL Health Technologies (WELL), the numbers tell two sharply different stories. The company keeps delivering record-breaking financial results, yet its stock remains stranded more than 50% below its all-time high — a divergence that is drawing the attention of value-focused investors.
In the first quarter of 2026, the Canadian digital health firm posted revenue of C$368.3 million, a 25% year-over-year increase. Adjusted EBITDA surged 56% to C$43.1 million, while net income doubled to C$15.5 million. Management reiterated full-year guidance of C$1.6 billion in revenue and C$180 million in adjusted EBITDA. The trajectory over a longer horizon is equally striking: revenue has expanded more than 360% over the past five years to reach C$1.4 billion in 2025, and adjusted earnings per share have climbed from C$0.05 to C$0.50.
The Canadian segment, which bundles clinics and the WellStar software platform, hit its C$100 million adjusted EBITDA target more than three quarters ahead of schedule — and did so on lower revenue than originally planned. It has since reached an annualized revenue run rate of C$100 million, driven by organic growth and two bolt-on acquisitions. As a result, the company now expects to raise its full-year EBITDA guidance above C$185 million.
Yet the stock tells a grimly different tale. Since peaking in February 2021, WELL shares have tumbled 53%. Even over a five-year stretch in which the S&P/TSX Composite Index has rallied more than 75%, the stock is down 26%. The explanation is widely pinned on the fervour of 2020–2021, when enthusiasm for healthcare digitization inflated valuations well beyond what the underlying business could support at the time. The subsequent sell-off has been a prolonged unwinding, even as the company expanded its clinic network and strengthened profitability.
Structural tailwinds are now building. WELL Health operates the largest outpatient care platform in Canada, with roughly 270 clinics delivering more than five million patient visits annually — more than double the volume handled by the country’s largest hospital system. Its digital backbone consists of three interconnected layers: WellStar for clinical workflows, HealWell for artificial intelligence, and CyberWell for data security.
On the policy front, new federal legislation is pushing for interoperability and curbing data blocking, while provinces increasingly favour domestically owned platforms for sensitive health data. In March 2026, Ontario unveiled a province-wide electronic medical record initiative backed by more than C$3.4 billion, a procurement process WELL has confirmed it will enter — one of only a handful of players with the scale to compete. The company’s long-term goal is to expand its share of outpatient primary care from roughly 1.5% today to 10% within eight to ten years, a target that implies annual revenue approaching C$7 billion. A C$400 million credit facility, a steady acquisition pipeline, and plans to spin out WellStar as a standalone public entity once its revenue reaches around C$100 million offer additional paths for value creation.
Analysts project free cash flow will grow from C$88.5 million in 2026 to C$177.5 million in 2028. At 10 times forward free cash flow, that trajectory suggests a potential return exceeding 60% over the next 18 months. With the stock currently trading below 20 times this year’s expected earnings and fundamentals consistently outpacing forecasts, the market is watching whether a long-overdue re-rating is finally taking shape.
